[VRDN] QoQ Quarter Result on 30-Sep-2015 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
13-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- -23.03%
YoY- -92.55%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 874 818 659 501 734 645 655 21.22%
PBT -2,507 -2,758 -2,980 -3,152 -2,562 -2,634 -2,258 7.22%
Tax 0 0 -47 0 0 0 0 -
NP -2,507 -2,758 -2,980 -3,152 -2,562 -2,634 -2,258 7.22%
Tax Rate - - - - - - - -
Total Cost 3,381 3,576 3,639 3,653 3,296 3,279 2,913 10.45%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin -286.84 -337.16 -452.20 -629.14 -349.05 -408.37 -345.00 -11.59%
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
EPS -3.50 -3.85 -4.19 -5.82 -4.94 -6.82 -5.85 -29.01%
EPS Diluted -3.50 -3.85 -4.19 -5.82 -4.94 -6.82 -5.85 -29.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.